Luca Edlira, Zitzmann Kathrin, Bornstein Stefan, Kugelmeier Patrick, Beuschlein Felix, Nölting Svenja, Hantel Constanze
Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091 Zurich, Switzerland.
Department of Medicine IV, University Hospital, LMU Munich, 80336 München, Germany.
Cancers (Basel). 2023 Sep 17;15(18):4601. doi: 10.3390/cancers15184601.
Immortalized cell lines originating from tumors and cultured in monolayers in vitro display consistent behavior and response, and generate reproducible results across laboratories. However, for certain endpoints, these cell lines behave quite differently from the original solid tumors. Thereby, the homogeneity of immortalized cell lines and two-dimensionality of monolayer cultures deters from the development of new therapies and translatability of results to the more complex situation in vivo. Organoids originating from tissue biopsies and spheroids from cell lines mimic the heterogeneous and multidimensional characteristics of tumor cells in 3D structures in vitro. Thus, they have the advantage of recapitulating the more complex tissue architecture of solid tumors. In this review, we discuss recent efforts in basic and preclinical cancer research to establish methods to generate organoids/spheroids and living biobanks from endocrine tissues and target organs under endocrine control while striving to achieve solutions in personalized medicine.
源自肿瘤并在体外单层培养的永生化细胞系表现出一致的行为和反应,并且在不同实验室能产生可重复的结果。然而,对于某些终点指标,这些细胞系的行为与原始实体瘤有很大不同。因此,永生化细胞系的同质性和单层培养的二维性不利于新疗法的开发以及将结果转化到体内更复杂的情况。源自组织活检的类器官和细胞系来源的球体在体外三维结构中模拟肿瘤细胞的异质性和多维特征。因此,它们具有重现实体瘤更复杂组织结构的优势。在本综述中,我们讨论了基础和临床前癌症研究中最近的努力,即在努力实现个性化医疗解决方案的同时,建立从内分泌组织和受内分泌控制的靶器官生成类器官/球体和活生物样本库的方法。